To identify patients who may benefit from EGFR targeted therapy, an 111In-labeled cetuximab tracer was developed for single photon emission computed tomography (SPECT) imaging of nude mice bearing FaDu HNSCC xenografts. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.